Search results for "Biomarker"

Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec Injection, with a low-dose...
Epigenetic Clocks Claiming to Measure Your 'True Age' Still Lack Scientific Standards

Epigenetic Clocks Claiming to Measure Your 'True Age' Still Lack Scientific Standards

"Chronological age: 50s. Body age: 30s. " This tagline has long been attached to celebrities praised for their meticulous health routines.
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger

Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival

Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
The Brain's Pain Network: Why Shingles Pain Lingers Long After the Rash Fades

The Brain's Pain Network: Why Shingles Pain Lingers Long After the Rash Fades

The red rash and painful blisters of shingles eventually clear completely. However, for a significant portion of...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...